Stock Chart

GMED

$86.93 -3.09%
Score: 56.4 HOLD
1Y Target $89.07 +2.5%
i
1Y Price Target

This target is derived from long-term trendline analysis and projected growth.

Note: Targets are based on the assumption that the current primary trend continues. They should be used as reference points, not guarantees.

Target may adjust dynamically as the stock trend reverses or accelerates.
LEAPs: SELL $90
i
LEAPs Option Signal

Type: SELL growth_1yr
Strike: $90
Premium: $5.70
Expiry: Mar 20, 2026
Target: $87
Score: -100

LEAPs are long-term options (1+ year) with less time decay.
30D Target: $93.58 - $95.67 STRONG_UPTREND
i
30D Trendline Target

This is a PROJECTED price range based on extrapolating the current trendline slope forward 30 days.

How it works:
• Draws support and resistance trendlines
• Calculates slope (rate of change)
• Projects lines to 30 days future

Signals:
● STRONG_UPTREND: Steep rise
● UPTREND: Moderate rise
● SIDEWAYS: Flat/Mixed
● DOWNTREND: Falling

⚠️ Not a prediction. Shows trend projection only.

R-squared: 0.83
Vol: 0.45x (vs SPY: 0.5x | vs QQQ: 0.4x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About GMED - GLOBUS MEDICAL INC

Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in …

Key Statistics

Market Cap $12B
P/E Ratio 29.25

This GMED stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track GMED's price movements with trendlines, gamma walls, and key support/resistance levels.